RUSHICKAH BROOKS: Open Payments
NPI 1093267981 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $546 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $180 |
| Tandem Diabetes Care, Inc. | 1 | $152 |
| Novo Nordisk Inc | 4 | $87 |
| Lilly USA, LLC | 3 | $71 |
| BETA BIONICS, INC. | 1 | $35 |
| Insulet Corporation | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $21 |
| Intra-Sana Laboratories | 1 | $18 |
Products named: FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, Ozempic, MOUNJARO, iLet Bionic Pancreas, Omnipod, STRENSIQ, JARDIANCE.
Industry payments across CT — which companies pay providers there.
